Figure 2. Flowchart of the 178 patients who underwent EBUS-TBNA.

^a Others included bronchogenic cyst, tuberculous lymphadenitis, inflammatory myofibroblastic tumor and leiomyoma. ^b The determination of benign diseases was based on results of clinical follow-up of at least 6 months demonstrating reduction in size or lack of apparent radiologic disease progression.